<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>26187708</identifier>
<setSpec>1579-2129</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Martínez Lacasa, Xavier</dc:author>
<dc:author>Sánchez Martínez, Paquita</dc:author>
<dc:author>García Gasalla, Mercedes</dc:author>
<dc:author>Mir Viladrich, Isabel</dc:author>
<dc:author>Solano-López, Guillermo</dc:author>
<dc:author>López Longo, Francisco Javier</dc:author>
<dc:author>García García, José Maria</dc:author>
<dc:author>Daudén Tello, Esteban</dc:author>
<dc:author>Taxonera Samso, Carlos</dc:author>
<dc:author>Dorca Sargatal, Jordi</dc:author>
<dc:author>Arias-Guillén, Miguel</dc:author>
<dc:description xml:lang="en">Tuberculosis risk is increased in patients with chronic inflammatory diseases receiving any immunosuppressive treatment, notably tumor necrosis factor (TNF) antagonists therapy. Screening for the presence of latent infection with Mycobacterium tuberculosis and targeted preventive treatment to reduce the risk of progression to TB is mandatory in these patients. This Consensus Document summarizes the current knowledge and expert opinion of biologic therapies including TNF-blocking treatments. It provides recommendations for the use of interferon-gamma release assays (IGRA) and tuberculin skin test (TST) for the diagnosis of latent tuberculosis infection in these patients, and for the type and duration of preventive therapy.</dc:description>
<dc:type>Consensus Development Conference</dc:type>
<dc:language>es</dc:language>
<dc:subject>Biologic therapies</dc:subject>
<dc:subject>Terapias biológicas</dc:subject>
<dc:subject>Técnicas de liberación de interferón gamma</dc:subject>
<dc:subject>Infección tuberculosa latente</dc:subject>
<dc:subject>Chronic inflammatory diseases</dc:subject>
<dc:subject>Enfermedades inflamatorias crónicas</dc:subject>
<dc:subject>Interferon-gamma release assays</dc:subject>
<dc:subject>Latent tuberculosis infection</dc:subject>
<dc:date>2016 Jan </dc:date>
<dc:title xml:lang="en">Consensus Document on Prevention and Treatment of Tuberculosis in Patients for Biological Treatment.</dc:title>
<dc:publisher>Archivos de bronconeumologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
